Myriad Genetics (MYGN) Other Non Operating Income (2009 - 2025)

Myriad Genetics has disclosed Other Non Operating Income across 17 years of filings, most recently posting $400000.0 for Q4 2025.

• In Q4 2025, Other Non Operating Income rose 33.33% year-over-year to $400000.0; the TTM figure through Mar 2026 stood at $700000.0 (up 200.0% YoY), while the FY2025 annual figure was $800000.0, down 27.27% from the prior year.
• Other Non Operating Income was little changed at $400000.0 in Q4 2025, from $400000.0 in the prior quarter.
• Over the last five years, Other Non Operating Income for MYGN reached as high as $120.6 million in Q3 2021 and fell as low as -$2.4 million in Q2 2023.
• The 5-year median for Other Non Operating Income is $100000.0 (2022), against an average of $8.1 million.
• Annual changes were most pronounced in 2021 — Other Non Operating Income jumped 7637.5% — and 2023, when it sank 2500.0%.
• A 5-year view of Other Non Operating Income shows it stood at $120.6 million in 2021, then tumbled by 99.59% to $500000.0 in 2022, then tumbled by 240.0% to -$700000.0 in 2023, then jumped by 142.86% to $300000.0 in 2024, then soared by 33.33% to $400000.0 in 2025.
• According to Business Quant data, Other Non Operating Income over the past three periods registered $400000.0, $400000.0, and -$100000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.